Wednesday, Oct 27 2021 | Time 03:01 Hrs(IST)
image
IndiaPosted at: Oct 27 2021 1:46AM


Covaxin: WHO seeks 'additional clarifications', no Emergency Use nod so far

By Ashish Srivastava
New Delhi, Oct 27 (UNI) The process to include indigenously developed COVID-19 vaccine, Covaxin, in Emergency Use Listing (EUL) of World Health Organisation (WHO) is delayed by a week as the Technical Advisory Group of the UN body has sought "additional clarifications" from the vaccine manufacturer.
The WHO, in an email response, told UNI that the TAG would reconvene on November 3 and conduct a final "risk-benefit assessment" for EUL of the Covaxin.
The decision has come after the WHO's TAG met on Tuesday to review data provided by Covaxin to decide the emergency use listing of the indigenously-made vaccine, which will pave its way to be administered globally.
"The TAG met today, 26 October 2021, (according to Central European Summer Time) and decided that additional clarifications from the manufacturer are needed to conduct a final EUL risk-benefit assessment for global use of the vaccine," the UN body stated in the email response to UNI.
"The TAG expects to receive these clarifications from the manufacturer by the end of this week, and aims to reconvene for the final risk-benefit assessment on Wednesday, 3 November," it added.
According to the UN agency, the "Technical Advisory Group for Emergency Use Listing (TAG-EUL) is an independent advisory group that provides recommendations to WHO on whether a Covid-19 vaccine can be listed for emergency use under the EUL procedure."
The WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Janssen, Moderna, and Sinopharm for emergency use.
The Hyderabad-based manufacturer of Covaxin had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine's EUL status, the WHO had informed earlier.
Last week, the UN body had said it is expecting one additional piece of information from Bharat Biotech regarding Covaxin and emphasised that it has to thoroughly evaluate to ensure vaccines are safe and "cannot cut corners" before recommending a vaccine for emergency use.
The Bharat Biotech's COVID-19 jab, along with Serum Institute of India's Covishield, was introduced to the nationwide immunisation programme against COVID-19 on January 16 this year.
UNI ASH GK
Tags: #Covaxin: WHO seeks 'additional clarifications'# no Emergency Use nod so far
More News

Pakistani terrorist's custody extended

27 Oct 2021 | 2:19 AM

New Delhi, Oct 26 (UNI) Police custody of Pakistani terrorist Ashraf alias Ali, who was arrested by Delhi Police Special Cell from Laxmi Nagar area, has been extended by eight days. The police are seeking a narco analysis test as he had not cooperated in the polygraph test, police sources said on Tuesday.

see more..

Delhi Govt's education model receives praises from Maha Minister

27 Oct 2021 | 1:54 AM

New Delhi, October 26 (UNI): Impressed with the state of education in the national capital, Minister of State (MoS) at Maharashtra Government Sanjay Bansode said on Tuesday that the Delhi model of education will be adopted in Maharashtra as well, office of Delhi Deputy Chief Minister Manish Sisodia said.

see more..

Covaxin: WHO seeks 'additional clarifications', no Emergency Use nod so far

27 Oct 2021 | 1:46 AM

By Ashish Srivastava
New Delhi, Oct 27 (UNI) The process to include indigenously developed COVID-19 vaccine, Covaxin, in Emergency Use Listing (EUL) of World Health Organisation (WHO) is delayed by a week as the Technical Advisory Group of the UN body has sought "additional clarifications" from the vaccine manufacturer.

see more..

Covaxin: WHO seeks 'additional clarifications' no Emergency Use nod so far

27 Oct 2021 | 1:38 AM

By Ashish Srivastava
New Delhi, Oct 27 (UNI) The process to include indigenously developed COVID-19 vaccine, Covaxin, in Emergency Use Listing (EUL) of World Health Organisation (WHO) is delayed by a week as the Technical Advisory Group of the UN body has sought "additional clarifications" from the vaccine manufacturer.

see more..

WHO seeks "additional clarifications" from Bharat Biotech, no emergency use nod so far

27 Oct 2021 | 1:11 AM

By Ashish Srivastava
New Delhi, Oct 27 (UNI) The process to include indigenously developed COVID-19 vaccine, Covaxin, in Emergency Use Listing (EUL) of World Health Organisation (WHO) is delayed by a week as the Technical Advisory Group of the UN body has sought "additional clarifications" from the vaccine manufacturer.

see more..
image